Sexual dysfunction and antihypertensive ...
Type de document :
Article dans une revue scientifique: Article original
PMID :
URL permanente :
Titre :
Sexual dysfunction and antihypertensive treatment: involvement of the different therapeutic classes and what to do about the treatment of hypertension
Auteur(s) :
Bouhanick, Béatrice [Auteur]
Blacher, Jacques [Auteur]
Huyghe, Eric [Auteur]
Colson, Marie Helene [Auteur]
Boivin, Jean-Marc [Auteur]
Mounier-Vehier, Claire [Auteur]
Hôpital cardiologique
Denolle, Thierry [Auteur]
Fauvel, Jean-Pierre [Auteur]
Blacher, Jacques [Auteur]
Huyghe, Eric [Auteur]
Colson, Marie Helene [Auteur]
Boivin, Jean-Marc [Auteur]
Mounier-Vehier, Claire [Auteur]
Hôpital cardiologique
Denolle, Thierry [Auteur]
Fauvel, Jean-Pierre [Auteur]
Titre de la revue :
La Presse Médicale
Nom court de la revue :
Presse Med
Numéro :
48
Pagination :
1222-1228
Éditeur :
Elsevier
Date de publication :
2019-07-11
ISSN :
2213-0276
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
Erectile dysfunction (ED) is not routinely discussed with patients in cardiology practices whereas it may impact the ability of patients to stay on therapy. Most of the studies about ED and antihypertensive therapies have ...
Lire la suite >Erectile dysfunction (ED) is not routinely discussed with patients in cardiology practices whereas it may impact the ability of patients to stay on therapy. Most of the studies about ED and antihypertensive therapies have several methodological limitations. Diuretics and beta-blockers have been shown to have a deleterious effect on ED. ISRA inhibitors, calcium antagonists, vasodilator beta-blockers and alpha-blockers have been shown to have a neutral impact on ED. Angiotensin 2 inhibitors, nebivolol and alpha-blockers use has sometimes beneficial effect on ED. In case of ED due to antihypertensive treatment, drugs can be switched each other but careful attention in patients with a high cardiovascular risk is required.Lire moins >
Lire la suite >Erectile dysfunction (ED) is not routinely discussed with patients in cardiology practices whereas it may impact the ability of patients to stay on therapy. Most of the studies about ED and antihypertensive therapies have several methodological limitations. Diuretics and beta-blockers have been shown to have a deleterious effect on ED. ISRA inhibitors, calcium antagonists, vasodilator beta-blockers and alpha-blockers have been shown to have a neutral impact on ED. Angiotensin 2 inhibitors, nebivolol and alpha-blockers use has sometimes beneficial effect on ED. In case of ED due to antihypertensive treatment, drugs can be switched each other but careful attention in patients with a high cardiovascular risk is required.Lire moins >
Langue :
Français
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
CHU Lille
Université de Lille
Université de Lille
Date de dépôt :
2019-12-09T16:48:01Z
2024-04-09T12:38:51Z
2024-04-09T12:38:51Z